(Q42120739)

16 October 2017

Diagnostic pitfall; interpretation of CA 19-9 concentrations in the presence of hepatic dysfunction (English)

1 reference

16 October 2017

Pearce S

1

1 reference

16 October 2017

Thornes H

series ordinal

2

1 reference

16 October 2017

Carr D

series ordinal

3

1 reference

16 October 2017

Tanner A

series ordinal

4

1 reference

16 October 2017

language of work or name

English

0 references

publication date

1 May 1994

1 reference

16 October 2017

1 reference

16 October 2017

35

1 reference

16 October 2017

5

1 reference

16 October 2017

707-708

1 reference

Role of the liver in clearance and excretion of circulating carcinoembryonic antigen (CEA)

16 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1374763

Hepatic Clearance of Serum Glycoproteins

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1374763

Initial clinical evaluation of an immunoradiometric assay for CA 19-9 using the nci serum bank

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1374763

Pancreatic function testing: serum PABA measurement is a reliable and accurate measurement of exocrine function

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1374763

Evaluation of a serologic marker, CA19-9, in the diagnosis of pancreatic cancer

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1374763

CA 19-9 in non-neoplastic liver diseases. A clinical and laboratory study

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1374763

CA 19-9 and CA 50 in benign and malignant pancreatic and biliary diseases

29 May 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/8200572

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Extra-hepatic cholestasis determines a reversible increase of glycoproteic tumour markers in benign and malignant diseases

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/8200572

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Pancreatic cancer versus chronic pancreatitis: diagnosis with CA 19-9 assessment, US, CT, and CT-guided fine-needle biopsy

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/8200572

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/GUT.35.5.707

1 reference

16 October 2017

1 reference

16 October 2017

1 reference